Ge Lou

机构：Harbin Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Second Affiliated Hospital of Harbin Medical University · ORCID：0000-0001-5405-7406

发表论文 50 篇 · 总被引 871 次 · h-index 15

代表论文

• Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer (2023 · JAMA Oncology · 被引 165)
• Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II study (2023 · International Journal of Gynecological Cancer · 被引 28)
• Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trial (2024 · EClinicalMedicine · 被引 24)
• A phase 1 trial of fuzuloparib in combination with apatinib for advanced ovarian and triple-negative breast cancer: efficacy, safety, pharmacokinetics and germline BRCA mutation analysis (2023 · BMC Medicine · 被引 16)
• Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer (2024 · BMC Medicine · 被引 7)
• First evidence of olaparib maintenance therapy in patients with newly diagnosed homologous recombination deficient positive/BRCA wild-type ovarian cancer: real-world multicenter study (2024 · Frontiers of Medicine · 被引 4)